The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $12.88 in the prior trading day, Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $11.93, down -7.38%. In other words, the price has decreased by -$7.38 from its previous closing price. On the day, 13.73 million shares were traded. SRPT stock price reached its highest trading level at $12.2948 during the session, while it also had its lowest trading level at $11.12.
Ratios:
Our goal is to gain a better understanding of SRPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.46 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.18.
On July 24, 2025, Citigroup started tracking the stock assigning a Sell rating and target price of $7.
BofA Securities Downgraded its Neutral to Underperform on July 23, 2025, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Nicaise Claude sold 2,491 shares for $99.64 per share. The transaction valued at 248,203 led to the insider holds 27,812 shares of the business.
Nicaise Claude bought 2,491 shares of SRPT for $248,226 on Mar 12 ’25. On Dec 12 ’24, another insider, Wigzell Hans Lennart Rudolf, who serves as the Director of the company, sold 10,500 shares for $124.84 each. As a result, the insider received 1,310,820 and left with 22,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 1172444672 and an Enterprise Value of 2006406016. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 1.03. Its current Enterprise Value per Revenue stands at 0.898 whereas that against EBITDA is -25.64.
Stock Price History:
The Beta on a monthly basis for SRPT is 0.43, which has changed by -0.91830444 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, SRPT has reached a high of $150.48, while it has fallen to a 52-week low of $10.41. The 50-Day Moving Average of the stock is -55.37%, while the 200-Day Moving Average is calculated to be -85.65%.
Shares Statistics:
The stock has traded on average 8.61M shares per day over the past 3-months and 23752960 shares per day over the last 10 days, according to various share statistics. A total of 98.25M shares are outstanding, with a floating share count of 93.47M. Insiders hold about 4.89% of the company’s shares, while institutions hold 96.12% stake in the company. Shares short for SRPT as of 1752537600 were 14856573 with a Short Ratio of 1.73, compared to 1749772800 on 9885949. Therefore, it implies a Short% of Shares Outstanding of 14856573 and a Short% of Float of 17.709999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
